Finance

Beta
Lists
PFE:NYSE
Pfizer Inc
$26.14
-0.27%
(-0.070) 1D
$26.12
-0.06% (-0.016)
After hours
Closed: May 28, 4:02:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PFE...
Open
$26.16
High
$26.28
Low
$26.01
Mkt. cap
148.98B
Avg. vol.
35.21M
Volume
25.58M
Dividend
6.58%
Quarterly dividend
$0.43
Ex-dividend date
May 8, 2026
P/E ratio
19.97
52-wk high
$28.74
52-wk low
$23.06
EPS
$1.31
Beta
0.35
Shares outstanding
5.70B
No. of employees
75K
Open
$26.16
High
$26.28
Low
$26.01
Mkt. cap
148.98B
Avg. vol.
35.21M
Volume
25.58M
Dividend
6.58%
Quarterly dividend
$0.43
Ex-dividend date
May 8, 2026
P/E ratio
19.97
52-wk high
$28.74
52-wk low
$23.06
EPS
$1.31
Beta
0.35
Shares outstanding
5.70B
No. of employees
75K
News stories
From sources across the web
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.75 / $0.72
+4.52%beat
Revenue / Est. (USD)
14.45B / 13.80B
+4.70%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
14.65B
16.65B
17.56B
14.45B
Cost of goods sold
3.50B
3.98B
5.06B
3.41B
Cost of revenue
3.50B
3.98B
5.06B
3.41B
Research and development expenses
2.44B
2.49B
3.32B
2.45B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.29B
3.08B
3.74B
2.84B
Operating expense
6.95B
6.80B
8.29B
6.48B
Total operating expenses
10.45B
10.78B
13.35B
9.88B
Operating income
4.20B
5.88B
4.20B
4.57B
Other non operating income
121.00M
181.00M
1.35B
36.00M
EBT including unusual items
3.04B
3.33B
-1.64B
3.17B
EBT excluding unusual items
3.83B
5.54B
5.09B
4.13B
Income tax expense
141.00M
-216.00M
-2.00M
461.00M
Effective tax rate
4.63%
-6.48%
0.12%
14.55%
Other operating expenses
-
-
-
-
Net income
2.91B
3.54B
-1.65B
2.69B
Net profit margin
19.86%
21.26%
-9.39%
18.59%
Earnings per share
0.78
0.87
0.66
0.75
Interest and investment income
156.00M
138.00M
247.00M
197.00M
Interest expense
-654.00M
-652.00M
-711.00M
-668.00M
Net interest expenses
-498.00M
-514.00M
-464.00M
-471.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.82B
7.53B
5.86B
6.18B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer